CD162

GWB-6E2CC0

6404

5D8. 8. 12 (PL2)

Spleen cells from immunised BALB/c mice were fused with cells of the mouse X63. Ag8. 653 myeloma cell line.

Phosphate buffered saline

Use 10ul of the suggested working dilution to label 106 cells or 100ul whole blood. Suggested

A SLe(x)-type glycan which through high affinity calcium-dependent interactions with E- P- and L-selectins mediates rapid rolling of leukocytes over vascular surfaces during the initial steps in inflammation. PSGL1 is critical for the initial leukocyte capture.

Membrane; Single-pass type I membrane protein.

Displays complex core-2 sialylated and fucosylated O-linked oligosaccharides at least some of which appear to contain poly-N-acetyllactosamine with varying degrees of substitution. Mainly disialylated or neutral forms of the core-2 tetrasaccharide Galbeta1--& gt; 4GlcNAcbeta1--& gt; 6(Galbeta1--& gt; 3)GalNAcOH. The GlcN:GalN ratio is approximately 2:1 and the Man:Fuc ratio 3:5. Contains about 14% fucose with alpha-1 3 linkage present in two forms: One species is a disialylated monofucosylated glycan and the other a monosialylated trifucosylated glycan with a polylactosamine backbone. The fucosylated forms carry the Lewis antigen and are important for interaction with selectins and for functioning in leukocyte rolling. The modification containing the sialyl Lewis X glycan is on Thr-57. No sulfated O-glycans. Some N-glycosylation.